-
1 month ago | 
zacks.com | Ethan Feller
The growing uncertainty and rising volatility in broad markets has me concerned, and I am currently focused on identifying defensive stocks that should hold up well in case there are further declines. Primo Brands Corporation (( - Free Report) ) is a leading consumer staples company, specializing in bottled water, beverage dispensers, and hydration solutions that serve millions across North America.
-
1 month ago | 
zacks.com | Ethan Feller
LGI Homes (( - Free Report) ) is a Texas-based homebuilder specializing in entry-level homes across key Sunbelt states, including Texas, Arizona, Florida, and Georgia. These markets thrived during the pandemic-era migration boom, but have since cooled significantly. After a surge in home prices from 2020 to 2022, many of these regions are now seeing price declines and weaker demand. As a result, LGI Homes has experienced slower sales growth and underwhelming stock performance.
-
1 month ago | 
zacks.com | Ethan Feller
It seems like a distinct possibility that the current market pullback could last for an extended period. Of course, I do not know the exact path the market will take moving forward, but the best thing we as investors can do is prepare for all the possible scenarios ahead of us, especially the worst case. If markets rebound from here, investors can resume the strategies we were all using before, following the AI boom and owning tech stocks.
-
1 month ago | 
flipboard.com | Ethan Feller
I last wrote about NVIDIA (NVDA) as the Bull of the Day on January 29 in the immediate aftermath of the DeepSeek invasion. I explained why buying near …
-
1 month ago | 
zacks.com | Ethan Feller
After carrying the stock market higher over the last two years, Vertiv (( - Free Report) ) and Nvidia (( - Free Report) ), two of the best performing stocks in the market, have been hammered lower by the recent stock market correction. Trade policy uncertainty, cutbacks on fiscal spending and a potential slowdown in the economy have investors feeling uneasy, adding to the volatility.
-
1 month ago | 
zacks.com | Ethan Feller
After two years of steady gains, the stock market is now experiencing one of its sharpest corrections in recent history. US stock indexes have entered correction territory, with technology and semiconductor stocks—the same industries that fueled the rally—leading the decline. Investor confidence has been shaken by uncertainty surrounding tariffs and broader economic policy under the new presidential administration. However, it’s important to put this market action into perspective.
-
1 month ago | 
dailytradealert.com | Ethan Feller
The US stock market has entered correction territory, with the S&P 500 8% off its recent all-time highs and the Nasdaq 100 down 11%. This sharp sell-off has been driven primarily by uncertainty surrounding tariff trade policy and to a lesser extent the effects of large federal spending cuts. Both catalysts have cut economic growth projections and added significant ambiguity for any businesses doing international trade.
-
1 month ago | 
businessandamerica.com | Ethan Feller
The US stock market has entered correction territory, with the S&P 500 8% off its recent all-time highs and the Nasdaq 100 down 11%. This sharp sell-off has been driven primarily by uncertainty surrounding tariff trade policy and to a lesser extent the effects of large federal spending cuts. Both catalysts have cut economic growth projections and added significant ambiguity for any businesses doing international trade.
-
1 month ago | 
zacks.com | Ethan Feller
The US stock market has entered correction territory, with the S&P 500 8% off its recent all-time highs and the Nasdaq 100 down 11%. This sharp sell-off has been driven primarily by uncertainty surrounding tariff trade policy and to a lesser extent the effects of large federal spending cuts. Both catalysts have cut economic growth projections and added significant ambiguity for any businesses doing international trade.
-
1 month ago | 
zacks.com | Ethan Feller
PetMed Express (( - Free Report) ) is built around an appealing concept—capitalizing on the rapidly growing pet ownership trend by offering pet medications and health products through an online platform. In theory, the company is well positioned in a market where pet spending continues to rise. However, its execution has failed to keep pace with industry growth, and the stock’s sharp decline over the past two years reflects a business struggling to maintain momentum.
